This inventor holds 2 USPTO granted patents. Top assignee: International Business Machines Corporation. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Joris Cadow: Innovator in Drug Compound Identification
Introduction
Joris Cadow is a notable inventor based in Winterthur, Switzerland. He has made significant contributions to the field of drug discovery, particularly in the identification of protein-targeted drug compounds. With a total of 2 patents, Cadow's work is at the forefront of innovative medical solutions.
Latest Patents
Cadow's latest patents include groundbreaking methods and systems for identifying drug compounds that target proteins in tissue cells. One of his notable inventions involves a neural network model that features an attention-based protein encoder and a molecular decoder. This model is designed to encode protein sequences into output vectors in a latent space, which represents proteins. The molecular decoder generates compound data from input vectors, ensuring that the two components work in tandem for effective drug identification.
Another significant patent is the idempotence-constrained neural network. This computer-implemented method focuses on enforcing an idempotent-constrained characteristic during the training of a neural network. By minimizing a loss function that includes an idempotence-based regularization term, Cadow's method enhances the training process of neural networks.
Career Highlights
Joris Cadow is currently employed at International Business Machines Corporation, commonly known as IBM. His role at IBM allows him to leverage his expertise in neural networks and drug discovery, contributing to advancements in healthcare technology.
Collaborations
Cadow has collaborated with talented individuals such as Matteo Manica and Antonio Foncubierta Rodriguez. These partnerships have fostered a creative environment that encourages innovation and the development of cutting-edge technologies.
Conclusion
Joris Cadow is a prominent figure in the realm of drug compound identification, with a focus on utilizing neural networks for medical advancements. His contributions through patents and collaborations highlight his commitment to innovation in healthcare.